HOW DOES PHOTODYNAMIC THERAPY WORK?

Photochemistry and Photobiology

Volumn 55, Issue 1, 1992, Pages 145-157

  Henderson, Barbara W ^a   Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RADIATION SENSITIZING AGENTS; RADIOSENSITIZING AGENT;

ANIMAL; CELL SURVIVAL; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; NEOPLASM; PHOTOCHEMOTHERAPY; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; HUMAN; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026494593     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1992.tb04222.x     Document Type: Review

References (101)

1. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution
2. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative‐mediated cutaneous photosensitization. Activation of the Xanthine Oxidase Pathway
3. The significance of the nature of the photosensitiser for photodynamic therapy: Quantitative and biological studies in the colon
4. Membrane lysis in Chinese hamster ovary cells treated with hematoporphyrin derivative plus light
5. Protection of murine skin and transplantable tumor against Photofrin‐II mediated photodynamic sensitization with WR‐2721
6. The time course of cutaneous porphyrin photosensitization in the murine ear
7. Distribution and elucidation of the tumor‐localizing component of hematoporphyrin derivative in mice
8. Genetic toxicology of the photosensitization of Chinese hamster cells by phthalocyanines
9. Photodynamic effects of hematoporphyrin‐derivative on enzyme activities of murine L929 fibroblasts
10. Photophysical studies of bacteriochlorophyll a and bacteriopheophytin a—singlet oxygen generation
11. Photobleaching of Photofrin II as a means of eliminating skin photosensitivity
12. Biological activities of phthalocyanines—III. Photoinactivation of V‐79 Chinese hamster cells by tetrasulfophthalocyanines
13. Biological activities of phthalocyanines—IX. Photosensitization of V‐79 Chinese hamster cells and EMT‐6 mouse mammary tumor by selectively sulfonated zinc phthalocyanines
14. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse
15. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors
16. Novel benzophenothiazinium photosensitizers: Preliminary in vivo results
17. Vascular occlusion and tumour cell death
18. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR‐2721 and WR‐77913
19. Cutaneous phototoxic occurrences in patients receiving Photofrin
20. Of what value is a highly absorbing photosensitizer in PDT
21. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages
22. Cytotoxic and mutagenic effects of the photodynamic action of chloroaluminum phthalocyanine and visible light in L5178Y cells
23. Drug and light dose dependence of photodynamic therapy: A study of tumor and normal tissue response
24. Modification of photodynamic therapy‐induced hypoxia by Fluosol‐DA (20%) and carbogen breathing in mice
25. Drug and light dose dependence of photodynamic therapy: A study of tumor cell clonogenicity and histologic changes
26. Studies on the mechanism of photodynamic therapy induced tumor destruction
27. Photo‐properties of a silicon naphthalocyanine: A potential photosensitizer for photodynamic therapy
28. Chemical mechanisms of photodynamic action
29. In vitro photosensitization of tumour cell enzymes by Photofrin II administered in vivo
30. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas
31. Delivery of the tumour photosensitizer zinc (II)‐phthalocyanine to serum proteins by different liposomes: Studies in vitro and in vivo
32. Photodynamic lipid peroxidation in biological systems
33. DNA damage and repair in CHO cells following hematoporphyrin photoradiation
34. Tissue distribution and photosensitizing properties of mono‐L‐aspartyl chlorin e6 in a mouse tumor model
35. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation
36. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions
37. Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation
38. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction
39. 2 from cells by photodynamic treatment in vitro
40. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor
41. Oxygen limitation of direct tumor cell killing during photodynamic treatment
42. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: Comparison to ionizing radiation
43. Bacteriochlorophyll‐a as photosensitizer for photodynamic treatment of transplantable murine tumors
44. Endothelial cell production of physiologic mediators in response to PDT in vitro and effects on platelet function
45. Vascular effects of photodynamic therapy in an intraocular retinoblastomalike tumour
46. In vivo transport and pharmacokinetic behaviour of tumor photosensitizers
47. Photoradiation therapy of brain tumours: Laboratory and clinical studies
48. In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative‐induced phototoxicity in mice
49. Porphyrin‐lipoprotein association as a factor in porphyrin localization
50. Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine
51. 125I]Iododihydrorhodamine 123 by four human tumor xenografts
52. The distribution of porphyrins with different tumor localising ability among human plasma proteins. Br
53. Effects of porphyrins on skin
54. Generation of eicosanoids from mast cells exposed to protoporphyrin and irradiation
55. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy
56. Photodynamic therapy in the treatment of pancreatic carcinoma: Dihematoporphyrin ether uptake and photobleaching kinetics
57. Protection against dihematoporphyrin ether sensitivity
58. Porphyrin photosensitization and carotenoid protection in mice; in vitro and in vivo studies
59. On the diffusion length of singlet oxygen in cells and tissues
60. Intracellular localization of photosensitizers
61. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK‐3025 cells
62. Metallopurpurins and light: Effect on transplantable rat bladder tumors and murine skin
63. Dihematoporphyrin ether‐induced photosensitivity in laryngeal papilloma patients
64. The interaction of tumor localizing porphyrins with collagen and elastin
65. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine
66. Urinary cytokines following photodynamic therapy for bladder cancer: A preliminary report
67. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells
68. Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy
69. In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine
70. The theory of PDT dosimetry: Consequences of photodestruction of sensitizer
71. Transport of light in tissue in photodynamic therapy
72. DNA lesions and DNA degradation in mouse lymphoma L5178Y cells after photodynamic treatment sensitized by chloroaluminum phthalocyanine
73. The effect of photodynamic therapy on the microcirculation
74. The response of the rat urinary bladder microcirculation to photodynamic therapy
75. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation
76. 3H‐Bpd‐MA), a new potent photosensitizer, in normal and tumor‐bearing mice
77. 6 for photodynamic therapy
78. 6 and Photofrin II
79. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers
80. 14C‐labeled disulfonated and trisulfonated gallium phthalocyanine in C3H mice
81. New trends in photobiology. Photosensitization of mitochondria. Molecular and cellular aspects
82. Clinical laser photodynamic therapy in the treatment of bladder cancer
83. Physiological factors in hyperthermia. NCI Monograph 61
84. Depolarization of mouse myeloma cell membranes during photodynamic action
85. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative Photoradiation observed in vivo in sandwich observation chambers
86. Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors
87. On the physical rationale of photodynamic therapy
88. Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminum sulphonated phthalocyanine (AISPc): A comparative study
89. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy
90. Detection of haematoporphyrin derivative and haematoporphyrin excited states in cell environments
91. Toxicity, tissue distribution and excretion studies of aluminum phthalocyanine tetrasulfonate in normal mice
92. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor
93. Photodynamic therapy: Light delivery and doseage for second‐generation photosensitizers
94. In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues
95. Effect of photosensitizer concentration in tissue on the penetration depth of photoactivating light
96. The effect of hematoporphyrin and light on human platelets. I. Morphologic, functional and biochemical changes